Advertisement

IR Playbook pp 313-322 | Cite as

Uterine Artery Embolization

  • Nicole A. Keefe
  • Ziv J Haskal
Chapter

Abstract

Uterine artery embolization (UAE) is a minimally invasive technique used to treat uterine fibroids, adenomyosis, and arteriovenous malformations. Fibroids are tumors that arise from the uterine smooth muscle and can cause significant pressure and bleeding symptoms for women. UAE is also a lifesaving procedure for postpartum hemorrhage or high-risk patients with placental abnormalities.

Keywords

Uterine artery embolization Fibroids Adenomyosis Arteriovenous malformation Postpartum hemorrhage Embolization Placenta accreta Placenta previa Placenta percreta 

References

  1. 1.
    Bozini N, Baracat EC. The history of myomectomy at the Medical School of University of Sao Paulo. Clinics (Sao Paulo). 2007;62(3):209–10.CrossRefGoogle Scholar
  2. 2.
    Aleksandrovych V, Bereza T, Sajewicz M, Walocha JA, Gil K. Uterine fibroid: common features of widespread tumor (review article). Folia Med Cracov. 2015;55(1):61–75.PubMedGoogle Scholar
  3. 3.
    Levy G, Hill MJ, Beall S, Zarek SM, Segars JH, Catherino WH. Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances. J Assist Reprod Genet. 2012;29(8):703–12.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Stewart EA. Clinical practice. Uterine fibroids. N Engl J Med. 2015;372(17):1646–55.CrossRefPubMedGoogle Scholar
  5. 5.
    Marshall LM, Spiegelman D, Goldman MB, Manson JE, Colditz GA, Barbieri RL, et al. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril. 1998;70(3):432–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Baird DD, Dunson DB. Why is parity protective for uterine fibroids? Epidemiology. 2003;14(2):247–50.PubMedGoogle Scholar
  7. 7.
    Medikare V, Kandukuri LR, Ananthapur V, Deenadayal M, Nallari P. The genetic bases of uterine fibroids; a review. J Reprod Infertil. 2011;12(3):181–91.PubMedPubMedCentralGoogle Scholar
  8. 8.
    McElin TW, Bird CC. Adenomyosis of the uterus. Obstet Gynecol Annu. 1974;3(0):425–41.PubMedGoogle Scholar
  9. 9.
    Ferenczy A. Pathophysiology of adenomyosis. Hum Reprod Update. 1998;4(4):312–22.CrossRefPubMedGoogle Scholar
  10. 10.
    Sharma K, Bora MK, Venkatesh BP, Barman P, Roy SK, Jayagurunathan U, et al. Role of 3D ultrasound and Doppler in differentiating clinically suspected cases of leiomyoma and adenomyosis of uterus. J Clin Diagn Res. 2015;9(4):QC08–12.PubMedPubMedCentralGoogle Scholar
  11. 11.
    ACOG Practice Bulletin. Alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol. 2008;112(2 Pt 1):387–400.Google Scholar
  12. 12.
    Laughlin SK, Hartmann KE, Baird DD. Postpartum factors and natural fibroid regression. Am J Obstet Gynecol. 2011;204(6):496 e1–6.CrossRefGoogle Scholar
  13. 13.
    Viswanathan M, Hartmann K, McKoy N, Stuart G, Rankins N, Thieda P, et al. Management of uterine fibroids: an update of the evidence. Evid Rep Technol Assess (Full Rep). 2007;154:1–122.Google Scholar
  14. 14.
    Carlson KJ, Miller BA, Fowler FJ Jr. The Maine Women’s health study: II. Outcomes of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstet Gynecol. 1994;83(4):566–72.CrossRefPubMedGoogle Scholar
  15. 15.
    Friedman AJ, Daly M, Juneau-Norcross M, Rein MS. Predictors of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist. Fertil Steril. 1992;58(2):413–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Letterie GS, Coddington CC, Winkel CA, Shawker TH, Loriaux DL, Collins RL. Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up. Fertil Steril. 1989;51(6):951–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Amirikia H, Evans TN. Ten-year review of hysterectomies: trends, indications, and risks. Am J Obstet Gynecol. 1979;134(4):431–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Gambone JC, Reiter RC, Lench JB, Moore JG. The impact of a quality assurance process on the frequency and confirmation rate of hysterectomy. Am J Obstet Gynecol. 1990;163(2):545–50.CrossRefPubMedGoogle Scholar
  19. 19.
    Keshavarz H, Hillis SD, Kieke BA, Marchbanks PA. Hysterectomy aurveillance – United States, 1994–1999. MMWR. 2002;51(SS05):1–8.Google Scholar
  20. 20.
    Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol. 2004;104(2):393–406.CrossRefPubMedGoogle Scholar
  21. 21.
    Jacoby VL, Jacoby A, Learman LA, Schembri M, Gregorich SE, Jackson R, et al. Use of medical, surgical and complementary treatments among women with fibroids. Eur J Obstet Gynecol Reprod Biol. 2014;182:220–5.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Gupta JK, Sinha A, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev. 2014;(12):CD005073.Google Scholar
  23. 23.
    Pundir J, Pundir V, Walavalkar R, Omanwa K, Lancaster G, Kayani S. Robotic-assisted laparoscopic vs abdominal and laparoscopic myomectomy: systematic review and meta-analysis. J Minim Invasive Gynecol. 2013;20(3):335–45.CrossRefPubMedGoogle Scholar
  24. 24.
    Takeda A, Manabe S, Hosono S, Nakamura H. Preoperative evaluation of submucosal myoma by virtual hysteroscopy. J Am Assoc Gynecol Laparosc. 2004;11(3):404–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Somigliana E, Vercellini P, Daguati R, Pasin R, De Giorgi O, Crosignani PG. Fibroids and female reproduction: a critical analysis of the evidence. Hum Reprod Update. 2007;13(5):465–76.CrossRefPubMedGoogle Scholar
  26. 26.
    Fadare O, Wang SA, Renshaw IL. Does the radiofrequency impedance-controlled endometrial ablation have any morphologic effects on uterine leiomyomata? Report of 3 cases. Diagn Pathol. 2008;3:28.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 81, May 2007. Obstet Gynecol. 2007;109(5):1233–48.CrossRefGoogle Scholar
  28. 28.
    Ravina JH, Herbreteau D, Ciraru-Vigneron N, Bouret JM, Houdart E, Aymard A, et al. Arterial embolisation to treat uterine myomata. Lancet. 1995;346(8976):671–2.CrossRefPubMedGoogle Scholar
  29. 29.
    Worthington-Kirsch RL. Uterine artery embolization: state of the art. Semin Interv Radiol. 2004;21(1):37–42.CrossRefGoogle Scholar
  30. 30.
    Goodwin SC, Spies JB, Worthington-Kirsch R, Peterson E, Pron G, Li S, et al. Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID registry. Obstet Gynecol. 2008;111(1):22–33.CrossRefPubMedGoogle Scholar
  31. 31.
    McLucas B, Voorhees WD, Elliott S. Fertility after uterine artery embolization: a review. Minim Invasive Ther Allied Technol. 2016;25(1):1–7.CrossRefPubMedGoogle Scholar
  32. 32.
    Siskin GP, Eaton LA Jr, Stainken BF, Dowling K, Herr A, Schwartz J. Pathologic findings in a uterine leiomyoma after bilateral uterine artery embolization. J Vasc Interv Radiol. 1999;10(7):891–4.CrossRefPubMedGoogle Scholar
  33. 33.
    Abbara S, Spies JB, Scialli AR, Jha RC, Lage JM, Nikolic B. Transcervical expulsion of a fibroid as a result of uterine artery embolization for leiomyomata. J Vasc Interv Radiol. 1999;10(4):409–11.CrossRefPubMedGoogle Scholar
  34. 34.
    Siskin GP, Tublin ME, Stainken BF, Dowling K, Dolen EG. Uterine artery embolization for the treatment of adenomyosis: clinical response and evaluation with MR imaging. AJR Am J Roentgenol. 2001;177(2):297–302.CrossRefPubMedGoogle Scholar
  35. 35.
    Kim MD, Kim S, Kim NK, Lee MH, Ahn EH, Kim HJ, et al. Long-term results of uterine artery embolization for symptomatic adenomyosis. AJR Am J Roentgenol. 2007;188(1):176–81.CrossRefPubMedGoogle Scholar
  36. 36.
    Bibi S, Ghaffar S, Memon S, Memon S. Severe acute maternal morbidity (SAMM) in postpartum period requiring tertiary hospital care. Iran J Reprod Med. 2012;10(2):87–92.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Kim TH, Lee HH, Kim JM, Ryu AL, Chung SH, Seok Lee W. Uterine artery embolization for primary postpartum hemorrhage. Iran J Reprod Med. 2013;11(6):511–8.PubMedPubMedCentralGoogle Scholar
  38. 38.
    Brown BJ, Heaston DK, Poulson AM, Gabert HA, Mineau DE, Miller FJ Jr. Uncontrollable postpartum bleeding: a new approach to hemostasis through angiographic arterial embolization. Obstet Gynecol. 1979;54(3):361–5.PubMedGoogle Scholar
  39. 39.
    Merland JJ, Houdart E, Herbreteau D, Trystram D, Ledref O, Aymard A, et al. Place of emergency arterial embolisation in obstetric haemorrhage about 16 personal cases. Eur J Obstet Gynecol Reprod Biol. 1996;65(1):141–3.CrossRefPubMedGoogle Scholar
  40. 40.
    Lédée N, Ville Y, Musset D, Mercier F, Frydman R, Fernandez H. Management in intractable obstetric haemorrhage: an audit study on 61 cases. Eur J Obstet Gynecol Reprod Biol. 2001;94(2):189–96.CrossRefPubMedGoogle Scholar
  41. 41.
    Fleming H, Ostör AG, Pickel H, Fortune DW. Arteriovenous malformations of the uterus. Obstet Gynecol. 1989;73(2):209–14.PubMedGoogle Scholar
  42. 42.
    Kim T, Shin JH, Kim J, Yoon HK, Ko GY, Gwon DI, et al. Management of bleeding uterine arteriovenous malformation with bilateral uterine artery embolization. Yonsei Med J. 2014;55(2):367–73.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Forssman L, Lundberg J, Scherstén T. Conservative treatment of uterine arteriovenous fistula. Acta Obstet Gynecol Scand. 1982;61(1):85–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Nicole A. Keefe
    • 1
  • Ziv J Haskal
    • 1
  1. 1.University of Virginia School of Medicine, Department of Radiology and Medical Imaging, Interventional Radiology DivisionCharlottesvilleUSA

Personalised recommendations